Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC36H36F3N3O2 |
InChIKeySVRXJVGEJNTFDZ-OMYKBPHGSA-N |
CAS Registry1456972-52-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | JP | 15 Feb 2014 |